News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,876 Results
Type
Article (76524)
Company Profile (478)
Press Release (701874)
Section
Business (212509)
Career Advice (3683)
Deals (37577)
Drug Delivery (122)
Drug Development (88025)
Employer Resources (183)
FDA (17837)
Job Trends (16409)
News (368701)
Policy (37660)
Tag
Academia (2964)
Alliances (54422)
Alzheimer's disease (1405)
Approvals (17770)
Artificial intelligence (208)
Bankruptcy (379)
Best Places to Work (12436)
Biotechnology (345)
Breast cancer (227)
Cancer (1705)
Cardiovascular disease (141)
Career advice (3127)
CAR-T (129)
Cell therapy (370)
Clinical research (70136)
Collaboration (661)
Compensation (323)
COVID-19 (2826)
C-suite (154)
Data (1553)
Diabetes (212)
Diagnostics (6674)
Earnings (81966)
Employer resources (159)
Events (120841)
Executive appointments (549)
FDA (18691)
Funding (585)
Gene therapy (259)
GLP-1 (757)
Government (4974)
Healthcare (20464)
Infectious disease (2935)
Inflammatory bowel disease (129)
Interviews (716)
IPO (17164)
Job creations (4458)
Job search strategy (2557)
Layoffs (499)
Legal (9215)
Lung cancer (253)
Manufacturing (253)
Medical device (14213)
Medtech (14217)
Mergers & acquisitions (20713)
Metabolic disorders (590)
Neuroscience (1836)
NextGen: Class of 2025 (7408)
Non-profit (5055)
Northern California (1969)
Obesity (339)
Opinion (255)
Patents (148)
People (61250)
Phase I (21696)
Phase II (30554)
Phase III (23030)
Pipeline (662)
Postmarket research (3252)
Preclinical (9674)
Radiopharmaceuticals (262)
Rare diseases (334)
Real estate (6763)
Regulatory (25254)
Research institute (2636)
Resumes & cover letters (586)
Southern California (1707)
Startups (3927)
United States (18225)
Vaccines (691)
Weight loss (257)
Date
Today (162)
Last 7 days (675)
Last 30 days (2813)
Last 365 days (37124)
2025 (2820)
2024 (37544)
2023 (42317)
2022 (53639)
2021 (58382)
2020 (57179)
2019 (50557)
2018 (38492)
2017 (36232)
2016 (36689)
2015 (42520)
2014 (36467)
2013 (32468)
2012 (34183)
2011 (34352)
2010 (33552)
Location
Africa (1143)
Arizona (219)
Asia (46444)
Australia (8136)
California (4568)
Canada (1617)
China (392)
Colorado (205)
Connecticut (232)
Europe (106377)
Florida (652)
Georgia (164)
Illinois (496)
Indiana (262)
Maryland (755)
Massachusetts (3638)
Michigan (203)
Minnesota (342)
New Jersey (1298)
New York (1308)
North Carolina (918)
Northern California (1969)
Ohio (171)
Pennsylvania (1051)
South America (1538)
Southern California (1707)
Texas (670)
Utah (135)
Washington State (466)
778,876 Results for "the michael j fox foundation for parkinson s research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
June 18, 2024
·
4 min read
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
Press Releases
NeuroDex Inc. Receives Grant from The Michael J. Fox Foundation to Advance Biomarker Research for Parkinson’s Disease
November 13, 2024
·
1 min read
Press Releases
C2N Diagnostics Partners with The Michael J. Fox Foundation to Uncover New Links Between Parkinson’s Disease, Lewy Body Dementia and Alzheimer’s Disease
January 15, 2025
·
5 min read
Pharm Country
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson’s Disease
The Michael J. Fox Foundation for Parkinson’s Research announced $9.75 million in total awards to five research teams working on tools to biologically measure and track the progression of Parkinson’s disease from its earliest detection through more advanced stages.
May 30, 2024
·
6 min read
Press Releases
Selonterra Awarded Second Grant from The Michael J. Fox Foundation for Parkinson’s Research
October 8, 2024
·
2 min read
Press Releases
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
October 9, 2024
·
5 min read
Press Releases
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
November 19, 2024
·
3 min read
Genetown
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson’s Research, a non-profit organization dedicated to finding a cure for Parkinson’s disease, announced a research project to accelerate research on genetic risk factors associated with PD, specifically targeting the role of variants in the GBA gene.
January 23, 2024
·
7 min read
Genetown
bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease
bit.bio, the company coding human cells for novel cures, announces the first project within a multi-year collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research to prioritise the development and delivery of a range of human cell products relevant to Parkinson’s disease.
March 5, 2024
·
5 min read
1 of 77,888
Next
